Table 1 Baseline characteristics of study patients
|  | MICT (n = 14) | HIIT (n = 42) | P value |
|---|---|---|---|
Age, mean (SD), years | 69 ± 14 | 68 ± 10 | P = .78 |
Female sex, n (%) | 5 (36) | 15 (36) | P > .99 |
Height, mean (SD), cm | 170 ± 10 | 171 ± 9 | P = .84 |
Body weight, mean (SD), kg | 91.2 ± 14.4 | 91.5 ± 16.3 | P = .95 |
BMI, mean (SD), kg/m2 | 31.5 ± 4.2 | 31.3 ± 4.7 | P = .90 |
Days between CR and MI, mean (SD), days | 14 ± 4 | 14 ± 11 | P = .34 |
Medical history, n (%) | |||
 PCI | 7 (50) | 24 (57) | P = .64 |
 CABG | 2 (14) | 6 (14) | P > .99 |
 Hyperglycemia | 11 (79) | 33 (79) | P > .99 |
 Hypertension | 8 (57) | 20 (48) | P = .54 |
 Dyslipidemia | 14 (100) | 39 (92) | P = .57 |
 Ever smoker | 5 (36) | 14 (33) | P > .99 |
Coronary angiography | |||
 One-vessel disease, n (%) | 6 (42) | 17 (40) | P = .88 |
 Two-vessel disease, n (%) | 4 (29) | 12 (29) | P = .99 |
 Three-vessel disease, n (%) | 4 (29) | 13 (31) | P = .74 |
Medications, n (%) | |||
 Insulin | 3 (21) | 9 (21) | P > .99 |
 Oral hypoglycemic drugs | 4 (29) | 15 (36) | P = .75 |
 Statins | 14 (100) | 42 (100) | P = .99 |
 ACEIs/ARBs | 9 (64) | 24 (57) | P = .64 |
 Antiplatelet drugs | 12 (86) | 41 (98) | P = .15 |
 Anticoagulants | 7 (50) | 26 (62) | P = .43 |
 Beta receptor blockers | 9 (64) | 37 (88) | P = .10 |
 CCBs | 2 (14) | 7 (17) | P > .99 |
 Diuretics | 2 (14) | 1 (2) | P = .15 |
 Nitrates | 4 (29) | 6 (14) | P = .25 |